NCT00863538View on ClinicalTrials.gov

Phase II Study of KPS-0373 in Patients With Spinocerebellar Degeneration (SCD)

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

Not specified

Conditions
Spinocerebellar Degeneration
Interventions
DRUG

KPS-0373

Trial Locations (3)

Unknown

Japan, Hokkaido Region

Japan, Kansai Region

Japan, Kanto Region

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY